Multiple Sclerosis Clinical Trials

A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233-0271

A clinical trial seeking patients for a research study for the treatment of Relapsing Multiple Scelrosis

Birmingham Alabama 35209

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis

Birmingham Alabama 35209

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study of AbobotulinumtoxinA and AbobotulinumtoxinA Placebo to evaluate Urinary Incontinence or Overactive Bladder

UPDATED

Cullman Alabama 35058

A clinical study for patients with Relapsing-Remitting Multiple Sclerosis

View More ▼

Cullman Alabama 35058

A clinical research study of ALKS 8700 for the treatment of Multiple Sclerosis (MS) (the EVOLVE-1 Study)

Cullman Alabama 35058

A clinical trial seeking patients for a research study for the treatment of Relapsing Multiple Scelrosis

Cullman Alabama 35058

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis

Cullman Alabama 35058

A clinical trial to evaluate treatments using ACTH and Placebo for patients with Multiple Sclerosis, Relapsing-Remitting

Cullman Alabama 35058

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Cullman Alabama 35058

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Homewood Alabama 35209

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

Mobile Alabama 36606

A clinical trial to evaluate treatments using Ofatumumab subcutaneous injection, Placebo orally matching to teriflunomide, Teriflunomide orally and Placebo subcutanous injection matching to ofatumumab for patients with Relapsing Multiple Sclerosis

Arizona

Center for Neurosciences
Tucson Arizona 85718

PASSAGE: Post Approval Safety Study Assessing Gilenya Experience

View More ▼

Gilbert Arizona 85234

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Gilbert Arizona 85234

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Gilbert Arizona 85234

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

UPDATED

Phoenix Arizona 85013

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Phoenix Arizona 85006

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Phoenix Arizona 85048

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Phoenix Arizona 85018

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Phoenix Arizona 85004

A clinical trial to evaluate treatments using Ofatumumab subcutaneous injection, Placebo orally matching to teriflunomide, Teriflunomide orally and Placebo subcutanous injection matching to ofatumumab for patients with Relapsing Multiple Sclerosis

Phoenix Arizona 85013

A clinical trial to evaluate treatments using Ofatumumab subcutaneous injection, Placebo orally matching to teriflunomide, Teriflunomide orally and Placebo subcutanous injection matching to ofatumumab for patients with Relapsing Multiple Sclerosis

Phoenix Arizona 85018

A clinical trial to evaluate treatments using Ublituximab and Placebo for patients with Multiple Sclerosis

Phoenix Arizona 85006

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Phoenix Arizona 85013

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

UPDATED

Scottsdale Arizona 85259

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

Tucson Arizona 85704

A clinical research study of ALKS 8700 for the treatment of Multiple Sclerosis (MS) (the EVOLVE-1 Study)

Tucson Arizona 85704

A clinical trial seeking patients for a research study for the treatment of Relapsing Multiple Scelrosis

Tucson Arizona 85704

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Tucson Arizona 85718

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Tucson Arizona 85741

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

California

Collaborative Neuro Science Network
Long Beach California 90806

A study of rHIgM22 dosage in relapsing MS patients.

Collaborative Neuro Science Network
Long Beach California 90806

Clinical trial studying the effects of RPC1063 in RMS

View More ▼

Berkeley California 94705

A clinical research study of ALKS 8700 for the treatment of Multiple Sclerosis (MS) (the EVOLVE-1 Study)

UPDATED

Berkeley California 94705

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Berkeley California 94705

A clinical trial to evaluate treatments using Ofatumumab subcutaneous injection, Placebo orally matching to teriflunomide, Teriflunomide orally and Placebo subcutanous injection matching to ofatumumab for patients with Relapsing Multiple Sclerosis

Berkeley California 94705

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

Carlsbad California 92011

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Carmichael California 95670

A clinical trial to evaluate treatments using Ofatumumab subcutaneous injection, Placebo orally matching to teriflunomide, Teriflunomide orally and Placebo subcutanous injection matching to ofatumumab for patients with Relapsing Multiple Sclerosis

Carmichael California 95608

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Costa Mesa California 92626

A clinical trial to evaluate treatments using ABT-555 and Placebo for patients with Multiple Sclerosis

Fresno California 93720

A clinical study for patients with Multiple Sclerosis

Fullerton California 92835

A clinical study for patients with Multiple Sclerosis

Fullerton California 92835

A clinical trial to evaluate treatments using Ofatumumab subcutaneous injection, Placebo orally matching to teriflunomide, Teriflunomide orally and Placebo subcutanous injection matching to ofatumumab for patients with Relapsing Multiple Sclerosis

Fullerton California 92835

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Hanford California 93230

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Hanford California 93230

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis